美股A股
StockGist
Back
8-K2026-04-13· deepseek-chat

ALLO · Allogene Therapeutics, Inc.

0001193125-26-152866

SEC filing

Summary

Allogene Therapeutics announced a proposed underwritten public offering of its common stock and suspended its existing at-the-market offering program.

Key takeaways